In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 63 for your search:
Drug:  fludeoxyglucose F 18
Find trials that include:  Any drugs shown
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 96-079, P30CA008748, MSKCC-96079, NCI-G97-1334, NCT00002930

2.

Phase: Phase III, Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000515329, UPCC-12199, UPCC-414500, NCT00194337

3.

Phase: Phase II, Phase I
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00600, CDR0000521453, ACRIN 6671, GOG-0233, GOG-0233-ACRIN 6671, U10CA027469, NCT00416455

4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000573917, NCCTG-N057K, N057K, NCT00553150

5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00267, MGH-07-344, R01CA129371, CDR0000593717, PHS 398/2590, 8030, P30CA006516, 07-344, NCT00662506

6.

Phase: Phase II
Type: Diagnostic
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: NCI-97-C-0068

7.

Phase: Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 99-004, MSKCC-99004, NCI-G99-1619, NCT00004152

8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 4 to 35
Sponsor: NCI
Protocol IDs: 020259, 02-C-0259, NCI-02-C-0259, NCT00047372, NCT00043979

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01438, 03-032, NCI-5917, CDR0000304738, MSKCC-03032, 5917, NCT00062374

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000362061, ACRIN-6668, RTOG-0235, NCT00083083

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000426417, ACOSOG-Z4033, SRC1, NCT00109876

12.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 6228, P30CA015704, UWCC-6228, UWCC-UW-6228, UW-04033, LILY-UW-04033, CDR0000441239, NCT00227539

13.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: CDR0000455012, U10CA021115, E3404, ECOG-E3404, NCT00274924

14.

Phase: Phase II
Type: Diagnostic
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-06-C-0099, NCI-P6831, NCT00316901

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: J0615 CDR0000492792, P30CA006973, JHOC-J0615, JHOC-NA_00002473, J0615, NCT00369681

16.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2009-01090, CDR0000499832, PBTC-022, U01CA081457, NCT00381797

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 070058, 07-C-0058, NCI-07-C-0058, NCI-P6840, 7358, NCT00436215

18.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000555009, CCCWFU 62306, IRB00001334, CCCWFU-IRB00001334, NCT00499447

19.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000561185, U10CA031946, CALGB-50602, NCT00516217

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00174, 2007-015, CDR0000564449, 7451, N01CM00038, U01CA062491, P30CA022453, U01CA062487, WSU-2007-015, NCT00527124

21.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000572604, U10CA031946, CALGB-50701, NCT00553501

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00257, CDR0000574114, UW-6143, UW IRB# 6143, 7958, N01CM37008, NCT00559377

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 6566, NCI-2010-00606, UWCC-6566, UWCC-UW-6566, UWCC-07-8678-H/A, NCT00564733

24.

Phase: Phase II
Type: Diagnostic
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00270, IRB #6590, CDR0000584077, UWCC-6590, 8052, 6590, NCT00602043

25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: JHOC-J0785, CDR0000586335, P30CA006973, JHOC-SKCCC-J0785, NA_00012756, SKCCC J0785, NCT00616967
1    
New Search